Stellus Capital Management closed its direct lending fund at $1.5 billion on May 19, reaching hard cap while sector-wide redemption notices rose 17% quarter-over-quarter through Q1 2026. The firm, which targets middle-market companies with $15M to $75M EBITDA, secured commitments from 31 institutional LPs, including three state pension systems and five family offices with $2B+ AUM each.

The fund structure carries a 1.75% management fee and 20% carry above an 8% hurdle, standard for middle-market direct lending but now requiring explicit illiquidity premiums in LP negotiations. Stellus deployed $340M of the capital within 48 hours of close, financing four sponsored buyouts in industrial services and healthcare IT, each with first-lien positions at L+575 to L+625 spreads. The firm maintains $4.2B in assets under management across three vehicles, all raised since 2019.

The timing matters because liquid credit alternatives bled $8.3B in net outflows during the same quarter, driven by interval fund gates and publicly traded BDC volatility. Allocators are bifurcating: they will tolerate 7-year lockups in private vehicles with proven sourcing networks, but they are abandoning semi-liquid structures that promised monthly redemptions and failed to deliver. Stellus benefits from a 22-year operating history and a default rate below 1.8% since inception, giving pension committees the audacity to lock capital through 2033.

The middle-market lending opportunity set expanded as regional banks retreated from sub-$100M EBITDA borrowers, creating $47B in unmet financing demand according to Lincoln International's Q1 survey. Stellus competes with Blue Owl, Golub Capital, and Ares for the same deals, but differentiation comes from speed—the firm can move from term sheet to close in 18 business days for borrowers it knows. That operational edge converted into $1.5B of LP capital while competitors struggled to reach first close.

Operators should watch Stellus deployment pace through Q3 2026, particularly whether the firm maintains current spread levels or compresses as competition intensifies. The four immediate deals suggest aggressive capital deployment rather than patient underwriting, a cadence that will reveal itself in the fund's first 12-month portfolio composition report due February 2027. Family offices that missed this raise should monitor the firm's next vehicle, likely a continuation fund targeting $2B+, expected to launch Q4 2026 if current deployment stays ahead of schedule.

The $1.5B close is not a sector rebound. It is evidence that institutional allocators will still write $50M tickets into illiquid credit if the manager has two decades of performance data and no gate controversies in the file.